Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients
NCT02119156
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
Belimumab
Sponsor
GlaxoSmithKline